These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23879486)

  • 1. Should we screen for lung cancer in Australia?
    Hew M; Stirling RG; Abramson MJ
    Med J Aust; 2013 Jul; 199(2):82-3. PubMed ID: 23879486
    [No Abstract]   [Full Text] [Related]  

  • 2. Lung cancer screening: USPSTF revises its recommendation.
    Campos-Outcalt D
    J Fam Pract; 2013 Dec; 62(12):733-40. PubMed ID: 24340335
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lung cancer screening with low-dose computerised tomography. Thoughts on its use in Spain].
    Ruano-Ravina A; Provencio-Pulla M; Casan Clarà P
    Med Clin (Barc); 2016 Oct; 147(8):366-370. PubMed ID: 27209225
    [No Abstract]   [Full Text] [Related]  

  • 4. Lung cancer screening poised to expand.
    Schmidt C
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25838443
    [No Abstract]   [Full Text] [Related]  

  • 5. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
    Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
    J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of lung cancer screening with low-dose computed tomography in heavy smokers: a microsimulation modelling study.
    Du Y; Sidorenkov G; Heuvelmans MA; Groen HJM; Vermeulen KM; Greuter MJW; de Bock GH
    Eur J Cancer; 2020 Aug; 135():121-129. PubMed ID: 32563896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of screening for lung cancer in Australia.
    Marshall HM; Finn N; Bowman RV; Passmore LH; McCaul EM; Yang IA; Connelly L; Fong KM
    Intern Med J; 2019 Nov; 49(11):1392-1399. PubMed ID: 31336016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of CT screening in the National Lung Screening Trial.
    Black WC; Gareen IF; Soneji SS; Sicks JD; Keeler EB; Aberle DR; Naeim A; Church TR; Silvestri GA; Gorelick J; Gatsonis C;
    N Engl J Med; 2014 Nov; 371(19):1793-802. PubMed ID: 25372087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Oncologic and financial implications of lung cancer screening.
    Pedersen JH; Sørensen JB
    Thorac Surg Clin; 2015 May; 25(2):223-9. PubMed ID: 25901566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer screening with low-dose CT (LDCT), or when a public health intervention is beyond the patient's benefit.
    Ruano-Ravina A; Heleno B; Fernández-Villar A
    J Epidemiol Community Health; 2015 Feb; 69(2):99-100. PubMed ID: 25138391
    [No Abstract]   [Full Text] [Related]  

  • 11. Timo J. Partanen (MSc, MPH, PhD) March 13, 1938-May 1, 2015.
    Scand J Work Environ Health; 2015 Jul; 41(4):419. PubMed ID: 26355180
    [No Abstract]   [Full Text] [Related]  

  • 12. Effective use of low-dose computed tomography lung cancer screening.
    Jeffers CD; Pandey T; Jambhekar K; Meek M
    Curr Probl Diagn Radiol; 2013; 42(5):220-30. PubMed ID: 24070715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals.
    Fitzgerald NR; Flanagan WM; Evans WK; Miller AB;
    Scand J Work Environ Health; 2015 Jul; 41(4):407-12. PubMed ID: 25837734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT screening for lung cancer: countdown to implementation.
    Field JK; Hansell DM; Duffy SW; Baldwin DR
    Lancet Oncol; 2013 Dec; 14(13):e591-600. PubMed ID: 24275132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer screening. The promise and pitfalls of a cancer breakthrough.
    Marshall E
    Science; 2010 Nov; 330(6006):900-1. PubMed ID: 21071639
    [No Abstract]   [Full Text] [Related]  

  • 16. Computed tomography screening for lung cancer: where are we now?
    Christensen JD; Tong BC
    N C Med J; 2013; 74(5):406-10. PubMed ID: 24165769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of Lung Cancer Screening in Canada.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    JAMA Oncol; 2015 Sep; 1(6):807-13. PubMed ID: 26226181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer screening: ready for prime time?
    Peres J
    J Natl Cancer Inst; 2011 Jan; 103(2):89-91. PubMed ID: 21191112
    [No Abstract]   [Full Text] [Related]  

  • 19. Computed tomographic screening for lung cancer: an opportunity to evaluate other diseases.
    Mets OM; de Jong PA; Prokop M
    JAMA; 2012 Oct; 308(14):1433-4. PubMed ID: 23047354
    [No Abstract]   [Full Text] [Related]  

  • 20. The time for low-dose computed tomography screening is now: a medical oncologist perspective.
    Levy BP; Becker DJ
    Oncology (Williston Park); 2014 Nov; 28(11):964-6. PubMed ID: 25381211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.